NSAIDs in cardiovascular diseases

Ang Cardio Balance Kapseln ay isang epektibo at ligtas na paraan para mapanatili ang kalusugan ng puso at pababain ang presyon ng dugo. Dahil sa kanilang natural na sangkap at mataas na bisa, nagiging maaasahang katuwang sila sa paglaban sa mataas na presyon ng dugo at sa pagpapabuti ng kalidad ng buhay. Leaves of the Banaba tree, also known as Crape Myrtle, offer multiple medicinal properties. Scientific studies and research found that it can lower triglyceride levels by 35% and increases good cholesterol level (HDL) by 14%. Not just that, the studies have also shown positive outcomes in cardiovascular diseases, diabetes, and blood pressure. It also has antioxidant properties and helps manage and control weight which ultimately causes the surge in blood flow pressure.

NSAIDs in cardiovascular disease: risks and clinical implications Non-steroidal anti-inflammatory Drugs (NSAIDs) are among the most commonly used drugs worldwide and are mainly used for the treatment of pain, inflammation and fever. Despite their wide distribution and OTC availability (over‑the‑counter) you are associated with a number of side effects, particularly in patients with existing cardiovascular disease (CVD). Pharmacological mechanisms of action and cardiovascular effects The effect of the NSAIDs is based on the inhibition of the Cyclooxygenase enzymes (COX‑1 and COX‑2), for the synthesis of prostaglandins responsible. Prostaglandins play an important role in the Regulation of vascular tone, platelet aggregation and Renal blood flow. The selective or non-selective inhibition of these enzymes can trigger the following cardiovascular effects: Increase in blood pressure through a reduction in vasodilator of prostaglandins and decreased renal function. Fluid retention: due to changes in renal perfusion and increased sodium retention. Thromboembolic events: in particular, in the case of selective COX‑2 inhibitors, which affect platelet function less, but the production of prostacyclin (PGI₂) in the vessel to inhibit walls. Epidemiological Evidence Several large observational studies and meta-analyses have shown that the intake is associated with the NSAIDs with an increased risk for cardiovascular events. In particular: an increased risk for myocardial infarction (MI), a higher incidence of stroke, an increase of congestive heart failure exacerbations, a possible risk for arrhythmic events. The risk seems to be dose and duration of intake and the specific NSAIDs to hang out. For example, it was described for Diclofenac significantly higher cardiovascular risk than for Naproxen. Risk groups Particularly patients with risk: of existing coronary heart disease (CHD), arterial hypertension, Diabetes mellitus, chronic renal failure Congestive heart failure. Also, elderly patients are exposed to due to Comorbidities and altered pharmacokinetics with an increased risk. Clinical Recommendations Before the regulation of NSAIDs, a careful Benefit-risk assessment should be performed, especially in patients with CVD or elevated cardiovascular risk profile. Recommendations include: The lowest effective dose for the shortest possible duration. Waiver of COX‑2‑selective inhibitors in patients with hollow cardiovascular risk. Preference for Naproxen in some cases, because it has a more favourable cardiovascular profile (but with an increased gastrointestinal risk). Regular monitoring of blood pressure, of renal function, and of Edema during therapy. Educating the patients about the symptoms of cardiovascular complications (e.g., chest pain, shortness of breath, sudden swelling). Conclusion NSAIDs can cause in patients with cardiovascular disease to significant cardiovascular side effects. An individual risk assessment in a differentiated Medicines selection and close Monitoring are crucial to ensure the safety of these drugs in clinical practice. Further research is needed to understand the long-term effects of various NSAIDs on the cardiovascular System.

Ginagamit ito bilang biologically active na pampadagdag sa pagkain - dagdag na pinagmumulan ng mga bitamina - B2, B6, C, mga organikong asido - mansanas, succinic, glutamine. Mga sangkap: malic acid, succinic acid, glutamic acid, badan extract, ascorbic acid, bitamina B2, B6. Una sa lahat, ang mga Beta-blocker ay karaniwang ibinibigay sa mga pasyente na may heart failure, aortic aneurysm, pagkatapos ng myocardial infarction, at sa mga kababaihan na nasa edad ng pagbubuntis, lalo na sa mga kababaihang nagpaplano ng pagbubuntis. Madalas matanggap ng katawan ang Beta-blocker, pero maaari rin itong magdulot ng pantal sa balat at bradycardia – sobrang bagal ng tibok ng puso.

Ang mga tableta para pababain ang presyon ng dugo ay natural na nakakatulong para mabilis itong bumalik sa normal, pero inirerekomenda rin na baguhin ang pamumuhay. Ang malusog na pagkain, kontrol sa timbang, regular na ehersisyo, at pag-iwas sa paninigarilyo at alak ay magagandang paraan para maiwasan ang mataas na presyon ng dugo. Siguraduhing mas kaunting sodium (hal. asin) at mas maraming potassium (mga saging, spinach, broccoli) ang mapapasok sa katawan.
NSAIDs in cardiovascular diseases

Nililinis ang mga ugat na kailangang alagaan mula sa deposito at pinananatili ang kinakailangang lakas ng tibok ng puso!

Punan ang form ng konsultasyon at order NSAIDs in cardiovascular diseases. Lilinawin ng operator ang lahat ng detalye sa iyo at ipapadala namin ang iyong order.

NSAIDs in cardiovascular diseases. Diseases of the circulatory System handicap.

Prevention of cardiovascular disease: measures and recommendations Cardiovascular diseases (CVD) are one of the leading causes of death worldwide. Targeted prevention can reduce the risk significantly, and the quality of life, and the life expectancy of the population. Primary prevention focuses on modifiable risk factors, including unhealthy diet, lack of physical activity, tobacco use, Obesity, and chronic Stress. Secondary prevention measures are aimed at patients with pre-existing risk factors or mild disease signs and include regular medical examinations, as well as drug therapy, if necessary. In the Following, the Central prevention systematized strategies, and in an overview table. Table: Preventive measures to reduce the risk of cardiovascular diseases Area Suggested Action Mechanism Of Action / Effect Recommended Implementation Nutrition reduction of saturated fats and sugar in the reduction of LDL‑cholesterol and blood sugar < 5% of daily calories from saturated fats; a maximum of 25 grams of sugar per day Increased consumption of dietary fiber, fruits, and vegetables to improve the intestinal flora, lowering blood pressure of at Least 400 g of fruit and vegetables daily (5 servings) Limiting salt consumption, reduction of arterial blood pressure < 5 g of NaCl per day (WHO‑recommendation) Physical activity Regular endurance training, strengthening of the heart muscle, improve vascular elasticity 150 minutes of moderate or 75 minutes of intense exercise per week Nicotine eliminating tobacco improvement of endothelial function, reduction of atherosclerosis, nicotine replacement therapy, counseling programs, if necessary Weight control achieving and maintaining a healthy BMI reduction of hypertension, risk of diabetes and lipid disorders BMI between 18.5 and 24.9 kg/m 2 Stress management relaxation techniques (e.g., Meditation, Yoga) reduction of stress hormones, blood pressure reduction, Regular application, at least 20 minutes a day Regular health checks, blood pressure, cholesterol, and blood sugar control, early detection of risk factors From the age of 40. The age of a year, with a family history of early Summary A multi-modal prevention, including Diet, physical activity, avoidance of Nicotine, weight control, and stress reduction, disease is the most effective strategy for the prevention of cardiovascular. The systematic implementation of these measures can reduce the individual risk significantly and at the same time the General health. Health education and individual counselling, play a Central role.